Get started

Hotstocks

Bullish Charts - Plasma Play, FDA Approved Plasma FacilitiesADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey. BREAKING NEWS TODAY - 07/30/2020 ADMA Biologics shares are trading higher following a report suggesting the company is near receiving emergency use authorization of Convalescent Plasma in COVID-19 patients. www.benzinga.com On July 6, 20, ADMA opened a new plasma facility and is awaiting emergency authorization for a second location. finance.yahoo.com With the FDA asking for everyone to donate plasma, this stock could rip! Plasma stocks ripped today and continue to rip. This company already is up and running one plasma facility. Game On! Long DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:ADMALong
by HotCharts
Bullish Charts - Coil, Pennant, Flag - Vans with DronesWorkhorse Group Inc. designs, manufactures, builds, sells, and leases battery-electric vehicles and aircraft in the United States. It operates through two divisions, Automotive and Aviation. The company also develops cloud-based and real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Its products include electric cargo vans, and medium and light-duty pickup trucks, as well as HorseFly delivery drones systems. The company was formerly known as AMP Holding Inc. and changed its name to Workhorse Group Inc. in April 2015. Workhorse Group Inc. was founded in 2007 and is headquartered in Loveland, Ohio. Today, there was an article on Dow Jones talking about Workhorse Pairing Vans with Drones to Drive Deliveries. www.barrons.com On 07/24/20, there was another article, "Trucks of the Future." & "Electric Trucks are the Future." workhorse.com - Beautiful Electric Truck On 07/23/20, Workhorse reported a purchase order for 20, C-1000 Electric Delivery Trucks. On 07/21/20, Workhorse talks about supplying electric trucks to the Postal Service. Does the news get any better? Yes, on 07/14/20, Workhorse announces Ryder will now offer the C-1000 All-Electric Step Vans for rental locations. On the Daily Chart, it looks to me like it's flagging, Bullish To some, it might look like an uptrending coil or a Bullish Pennant. No matter how you look at the daily chart, it looks to me like a very Bullish setup. RSI is turning up, Bullish OBV is turning up, Bullish Stochastic is turning up, Bullish Accumulation is Bullish I see big things coming for this company! Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:WKHSLong
by HotCharts
Moderna in Trouble - ABUS Wins Lawsuit Tied to COVID-19 DrugArbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-836, a capsid inhibitor that has the potential to inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is in pre-clinical studies. The company also develops RNAi drugs, which utilize the RNA interference pathway, allows for a novel approach to treating disease. Its RNAi HBV candidates are designed to reduce hepatitis B surface antigen expression in patients chronically infected with HBV. In addition, it develops AB-729, a second generation RNAi therapeutic targeted to hepatocytes; HBV RNA destabilizer, an orally active agent that cause the destabilization of HBV RNAs, which leads to RNA degradation and to reduction in HBsAg levels. Further, the company engages conducting a Phase 1a/1b clinical trial and several pre-clinical and investigational new drug-enabling studies to evaluate proprietary HBV therapeutic agents, together with standard of care therapies, and in combination with each other. It has strategic alliance, licensing, and research collaboration agreements with Marqibo; Gritstone Oncology, Inc.; and Acuitas Therapeutics, Inc. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania. AFTER HOURS BREAKING NEWS Moderna stock tumbled late Thursday after the biotech lost a patent battle that may jeopardize the financial future of its coronavirus vaccine. Moderna (MRNA) challenged patents held by Arbutus Biopharma (ABUS) covering lipid nanoparticle, or LNP, technology. Lipid nanoparticles are the delivery system for messenger RNA drugs, including Moderna's coronavirus vaccine, which is known as mRNA-1273. Despite the company's contention, the ruling could cut into profits on any Moderna drug, including mRNA-1273, says SVB Leerink analyst Mani Foroohar. "Revenue concentration in (the coronavirus vaccine) is a central feature of the investment case for Moderna shares," Foroohar said. "Any meaningful royalty burden could hamper Moderna's pricing flexibility and margin profile vs. other players in the SARS-CoV-2 vaccine market." Foroohar called the decision in Arbutus' favor "a disappointing turn for Moderna." "This decision opens the door to a fascinating (and likely protracted) period of investor controversy and debate around the implications of any potential infringement of claims by Arbutus regarding Moderna's use of Lipid Nanoparticle delivery technology, and any further actions Moderna may take to defend their own (intellectual property) position and freedom to operate," he said. NEWS: www.investors.com Where's ABUS going? To $100.00 ...??? On the monthly chart, it looks like $9.00 might be the next stop..? At this point, I am not sure if there is a top right now for ABUS. The news is huge for ABUS and could entitle ABUS to billions in profits and revenue from the COVID-19 vaccine. Intelligent comments welcome. DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:ABUSLong
by HotCharts
4
Bullish Charts - FDA Grants Orphan Drug Designation for LymphomaMiragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need. Its four lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various pathological fibrotic conditions, including cutaneous and ocular fibrosis, which is in Phase II clinical trial; MRG-229, which is in preclinical trial for the treatment of idiopathic pulmonary fibrosis; and MRG- 110, an inhibitor of miR-92, a microRNA expressed in endothelial cells, which has completed two Phase I clinical trial for the treatment of heart failure, wound healing, and other ischemic disease in the United States and Japan. Miragen Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado. LATE BREAKING NEWS AFTER HOURS - POSSIBLY A BIG SPIKE IN THE MORNING miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that the Food & Drug Administration (FDA) has granted orphan drug designation to cobomarsen, for the treatment of T-cell lymphoma. DAILY CHART IS BULLISH OBV is Bullish MACD turned up Bullish RSi crossed center line and turned up, Bullish PMO is turning up, Bullish This little stock could spike hard. Best of luck everyone! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
MLong
by HotCharts
Bullish Charts - Robust Earnings, Undervalued & 7.79% YieldNavient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates through four segments: Federal Education Loans, Consumer Lending, Business Processing, and Other. The company holds and acquires Federal Family Education Loan Program loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, and federal education loans owned by the United States Department of Education and other institutions. It also holds, originates, and acquires consumer loans; and performs servicing activities on its own education loan portfolio, including private education loans, and private education refinance loans. In addition, the company offers revenue cycle management and business processing services; and healthcare services that include revenue cycle outsourcing, accounts receivable management, extended business office support, and consulting engagement for federal, state, and municipal clients; public authorities; and healthcare organizations. Further, it provides customizable solutions for its clients that include hospitals, hospital systems, medical centers, large physician groups, and other healthcare providers; and corporate liquidity portfolio and debt repurchase services. The company was founded in 1973 and is headquartered in Wilmington, Delaware. 07/21/20, Navient Q2 Earnings Blew Away Wall Street Estimates Daily Chart looks Bullish with indicators turning up, positive. BULLISH The company has a current P/E of only 4.94x Current EPS: $1.54 Yield: 7.79% Reported Earnings: Q2 EPS $0.91 Beats $0.47 Estimate Market Cap: 1.5 Billion Institutional Ownership: 98.17% In my opinion, the stock is DIRT CHEAP at current levels. Compare this company's earnings to Bank of America & Wells Fargo, NAVI is blowing away Bank of America earnings along with many other large banks including Wells Fargo! I think NAVI should be trading around $30.00 all day long with the earnings the company is delivering. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:NAVILong
by HotCharts
2
Spotify Rumored Buyout of SONO - $4 Billion or more, Over $31Sonos, Inc., together with its subsidiaries, designs, develops, manufactures, and sells multi-room audio products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides wireless speakers, home theater speakers, components, and accessories. It offers its products through approximately 10,000 third-party retail stores, including custom installers of home audio systems; and e-commerce retailers, as well as through its Website sonos.com. The company was formerly known as Rincon Audio, Inc. and changed its name to Sonos, Inc. in May 2004. Sonos, Inc. was founded in 2002 and is headquartered in Santa Barbara, California. "We are hearing from a European desk (Spotify is based in Sweden) that Spotify is preparing a roughly $4 billion bid to acquire home entertainment company Sonos (over $31 per share). There has been talk of an interest by Apple in Sonos, but the Sonos board is prepared to go ahead with Spotify. Dont know stock/cash terms." Lets see what happens. Rumor SONO will be bought has been circulating for several months. Today's price action tells us something is brewing! Best of luck folks! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:SONOLong
by HotCharts
1
Bullish Charts - Vaccine Reduced COVID-19 into Common ColdAbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois. On 07/15/20, Researchers said AbbVie's Tricor reduced severity of COVID-19 into "NOTHING WORSE THAN A COLD." www.yahoo.com In my opinion, a vaccine doesn't get any better than this. AbbVie has the vaccine! Where is all the great news about Tricor killing COVID-19.??? If the stock can break through around $107, I think it's going to spike hard! The daily chart looks great. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:ABBVLong
by HotCharts
NIO ES6 - Amazing Vehicle! - Watch This VideoJust an FYI for NIO shareholders. I thought you would be very interested in this video. I also think this vehicle is a Tesla killer. I think China will eventually shut out Tesla & NIO will take over the Chinese Electric Vehicle Market. www.youtube.com Again, after watching stocks like SOLO, SPCE, WKHS, SHLL, SPAQ, NKLA, NFYEF & AYRO trade at crazy multiples with nothing to show for it, I think NIO is DIRT CHEAP! In my opinion, NIO should be trading in the $50 to $100 range right now! NIO is years ahead of the competition. I think it will take other electric vehicle companies several years to catch NIO. Best of luck with your trades! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NIOLong
by HotCharts
Bullish CHarts - Undervalued, $1.1 B in Sales, 97.3K New UsersEndurance International Group Holdings, Inc., together with its subsidiaries, provides cloud-based platform solutions for small-and medium-sized businesses in the United States and internationally. The company operates in three segments: Web Presence, Domain, and Email Marketing. It offers Web hosting services, including entry-level shared hosting, and virtual private server and dedicated hosting solutions; Website building tools; domain registration, management, and resale services; malware protection solutions to protect subscribers' Websites from viruses, malicious code, and other threats; and backup control solutions that enable subscribers to schedule, maintain, manage, and restore backups of their online data and Websites. The company also provides email marketing solutions that enable subscribers to communicate with their customers and potential customers through email; products that enables subscribers to sell their products and services online, including secure and encrypted payments, shopping carts, inventory management, online marketplace listing solutions, payment processing and related services, and mobile payments; and search engine optimization and marketing solutions. In addition, it offers solutions that allow subscribers to have their Websites and email marketing campaigns rendered on mobile devices; tools and services that enable subscribers to communicate with their customers and potential customers through social networks; business productivity tools that include professional email, word processing and presentation software, online storage, shared calendars, and video meetings; control panels and dashboards that offer subscribers with tools to analyze activity on their Websites; and professional services, including Website design, marketing, social media management, and Website migration services. The company was founded in 1997 and is headquartered in Burlington, Massachusetts. Many traders may not realize, this company owns some prominent & well known assets including CONSTANT CONTACT, BLUEHOST, HOSTGATOR & DOMAIN.COM among others. Many of these services we all use on a daily basis. On 07/14/20, Endurance announced Prelim. Q2 Sales of $274 Million, Net Subscriber Additions of 97,3K, and FY20 Sales of $1.1 BILLION On 07/15/20, Credit Suisse Lifted the price target on Endurance to $9.00 - (I think this is very conservative especially after seeing the assets the company owns) The Daily Chart looks BULLISH 50-Day MA is about to cross up and over the 200-Day MA, BULLSIH Volume is Green, Bullish PMO is Bullish MACD is Bullish RSI is Bullish Stochastic is Bullish OBV is Bullish Accumulation is Bullish Folks, if you look back at our previous research picks, we've made a lot of great calls. Look at APT, WRTC & SPCE today, to name a few. We think this stock is worth at minimum, $15 to $20 a share after looking at the assets they own. We think the assets are worth more than the stock price right now. CONSTANT CONTACT, BLUEHOST & HOSTGATOR are very well known in the technology industry. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
ELong
by HotCharts
Timeline: NIO vs. TSLA = NIO Target $350 to $500Don't shoot the messenger! I have a timeline of Tesla below which should put a price target on NIO North of $400 to $500 a share. www.thestreet.com As we stand today, NIO is much more successful than Tesla ever was and at this time, or there a bouts, compared to Tesla at or around the same time period in production & sales, Tesla was trading north of $360 a share and only delivered 2,400 cars compared to NIO delivering over 46,000 vehicles. "Entering 2018 Tesla faced several difficulties. Missed predictions had led investors to dump the company's stock, and in the middle of 2017 it lost more than 5% of its value in a collapse worth $12 billion. By January, 2018 Tesla was producing its Model 3 sedans at a fraction of the rate it had anticipated. Over a three-month period the company managed to finish and ship 2,400 cars after promising consumers and investors that it could complete more than 5,000 per week." On 07/02/2020, NIO announced as of June 30, NIO delivered 46,082 vehicles with 14,169 already delivered for 2020. These sales figures topple what Tesla sold and at or around the same time period, Tesla stock spiked to around $389.61. These are real figures from the Tesla timeline I have listed herein and using monthly stock charts for Tesla's stock price at that time period. NIO is also in much better financial condition than Tesla ever was at or around the same time in the production and sales cycle / timeline. Folks, when you look at the monthly stock prices for Tesla, and compare the timeline link I have herein, NIO is extremely cheap and deeply undervalued at current levels. Also, NIO has the Chinese Government behind them. Tesla, at or around when the company started, only raised $500 million from a DOE loan and Tesla was burning cash like water. NIO just raised almost $1 Billion in funding. NIO is financially in a better place than what Tesla ever was. The way I see it, the Chinese Government will not let NIO fail to Tesla, a USA auto company. In my opinion, after researching Tesla vs. NIO, I personally think NIO should be trading at or around $350 to $500 a share with their financial and sales figures. Best of luck longs! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NIOLong
by HotCharts
12
Virgin Secures Financial Package of $1.5 Billion - Huge Win!Just an FYI... If anyone missed this today... At approx. 1:59 PM today, news was announced that Richard Branson Secured a financial package for Virgin Atlantic of about $1.5 Billion. www.barrons.com This is also great news for Virgin Galactic Holdings, Inc. because it takes financial pressure off all the Richard Branson companies as a whole. Also, on another note... I've heard rumors the FAA gave Virgin Galactic the long awaited license it needs for space travel. So we should have some great news forthcoming! Daily Chart SPCE is trading above the cloud and bounced up off support today to close up for the day, +0.33 at $18.43. PMO is Bullish RSI is Bullish OBV is Bullish Accumulation is Bullish Where's the stock going from here? My guess...to the moon! Best of luck longs! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:SPCELong
by HotCharts
Bullish Charts - Robust Earnings, Electric Vehicle TechnologiesGarrett Motion Inc. designs, manufactures, and sells turbocharger and electric boosting technologies for light and commercial vehicle original equipment manufacturers and the aftermarket worldwide. The company offers light vehicle gasoline and diesel, and commercial vehicle turbochargers. Its integrated vehicle health management tools detect intermittent faults and anomalies to provide understanding of the real-time health of a vehicle system. The company offers its products through distribution networks. Garrett Motion Inc. was incorporated in 2018 and is headquartered in Rolle, Switzerland. Daily Chart looks great! Volume, Bullish PMO, Bullish MACD, Bullish RSI, Bullish Stochastic, Bullish On Balance Trending Up, Bullish Accumulation Trending Up, Bullish It looks like the stock price broke out above the cloud at or around the $5.73 range. On 05/11/20, the company announced a huge spike in EPS. Q1 EPS $0.91, Sales $745.000 Million, Beat $664.040 Million Wall Street Estimates This one sentence sums up why the company is seeing a surge in revenue and earnings... "Garrett Motion Inc. designs, manufactures, and sells turbocharger and electric boosting technologies for light and commercial vehicle original equipment manufacturers and the aftermarket worldwide. " The electric vehicle industry is red hot! Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
GLong
by HotCharts
Bullish Charts - The Space Force, News ForthcomingVirgin Galactic Holdings, Inc., an integrated aerospace company, develops human spaceflight for private individuals and researchers. It also manufactures air and space vehicles. The company's spaceship operations include commercial human spaceflight, flying commercial research, and development payloads into space. In addition, it designs, develops, and manufactures ground and flight testing systems, as well as provides post-flight maintenance services for spaceflight vehicles. Virgin Galactic Holdings, Inc. was founded in 2007 and is based in Las Cruces, New Mexico. SPCE was upgraded a few minutes ago to a BUY On 07/02/20, Virgin announced it will reveal the design of SpaceShipTwo's Cabin Interior via Livestream on July 28, 2020. On 07/01/20, Virgin announced it is getting closer to obtaining an FAA License for Space Travel. (This alone should make the stock spike upon approval of the license) On 06/23/20, NASA announced it is stepping up support for Space Tourism. Virgin could be the Tesla of Space Travel. Daily Chart is Bullish Volume is Bullish PMO is Bullish MACD is Bullish RSI is Bullish Stochastic is Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:SPCELong
by HotCharts
3
Bullish Charts - COVID-19 VaccineGilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology. The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Second Genome; Gadeta; Carna Biosciences Inc.; Nurix Therapeutics, Inc.; Humanigen, Inc.; Kiniksa Pharmaceuticals, Ltd.; Kyverna Therapeutics, Inc.; Glympse Bio, Inc.; Renown Institute for Health Innovation; Goldfinch Bio, Inc.; Insitro, Inc.; Novo Nordisk A/S; Yuhan Corporation; Kite Pharma, Inc.; oNKo-innate Pty. Ltd.; and Roche Holding AG. The company has partnership with Arcus Biosciences, Inc. to co-develop and co-commercialize next-generation cancer immunotherapies. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California. On 07/11/20, Gilead announced its drug Remdesivir can reduce risk of death in COVID-19 patients. On 07/10/20, Former FDA Commissioner Scott Gottlieb said Remdesivir data showed improved COVID-19 Recovery & Reduced Risk of Death by 62%. The COVID-19 drug alone could be a huge revenue boom for Gilead into the future as many countries stockpile & use it. On the Daily Chart, it looks to me like a Pennant has formed with a breakout coming, Bullish Volume, Bullish PMO, Bullish MACD, Bullish RSI, Bullish OBV, Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:GILDLong
by HotCharts
1
Bullish Industry - Protective Gear, N95 Masks, Robust EarningsAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada. On 06/25/20, Alpha Pro announced it will join the Russell 2000 and Russell 3000 Indexes. The company is also currently included in the Russell Microcap Index. On 06/23/20, Business Wire announced Aplha Pro serves a $15 Billion dollar Worldwide industry. On 05/06/20, Alpha Pro announced ROBUST earnings that blew away Wall Street estimates. Q1 EPS $0.39 up from $0.09 YoY. In addition, Alpha Pro had 16% growth in its Building Supply segment. The company has experienced a SURGE in customer demand for its "Proprietary" N-95 Particulate Respirator face mask and other PPE products as a result of the pandemic. As of May 1, 2020, the company has approx. $46.8 million in orders for the N-95 mask alone. Alpha Pro has also experienced a robust demand for its "Face Shield" products with orders totaling $13.3 Million as of May 1, 2020. Alpha Pro ended the 1st qtr of 2020 with working capital of $31.6 million and a current ration of a solid 4:1 - (Bullish Ratio - Strong Cash Position) The company currently has NO OUTSTANDING DEBT and an unused $3.5 million credit line. With the recent uptick in COVID-19 infections, more and more states are requiring masks for all activities especially for frontline employees. The need for Alpha Pro products is not going away anytime soon. Rapid Growth should continue far into 2021 and beyond. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
AMEX:APTLong
by HotCharts
Game Changer - NIO Secures $1.4 Billion in FinancingHi Longs... If you did not see this, here it is. Rumor is, NIO has secured an additional $1.4 Billion in funding from 6 Chinese Banks. See link below China "WILL NOT" let NIO fail! cntechpost.com Also, I think today was a major breakout. Why? On September 4, 2018, NIO hit an all time high of $13.80 and today, the stock closed well above that price. With the old high taken out today, I don't see any overhead resistance. I think this stock is going to $50 real soon especially if and when the shorts start covering almost 150 million shares they control. If you're short, you need to start covering because I think China will cause the biggest short squeeze in the history of Wall Street very soon! By betting against NIO, you are betting China fails. As you know, China will not let that happen. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NIOLong
by HotCharts
12
NIO Sedan Coming. It's Amazing & Beautiful - See Photos HereJust an FYI for all the NIO longs...! Get ready, with almost 150 million shares short, NIO could blast off like a rocket ship soon! Investors want to be in this stock before the news hits! Nio’s first electric sedan (Tesla Model S challenger?) to be launched this year April 25, 2020 4:28 pm by Bala Natarajan electricvehicleweb.in I am hearing the sedan launch could be announced at any time. NIO might also be taking orders too. China is determined to become the global center for EV production and is using quotas and subsidies to get there. Also, to all the short sellers betting against NIO, with over 40,000 vehicles sold to Tesla's 300,000, NIO is not far behind. Keep in mind, China Population: 1.4 Billion = Millions of "Chinese Made" electric vehicles sold. The new NIO Sedan should sell over 500,000 cars alone, not counting NIO's other SUV vehicles, and this compares to Tesla's 300,000 for "" ALL "" their vehicles - There's no comparison! NIO WINS! Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NIOLong
by HotCharts
3
Bullish Sector - Booming Revenue, Joining Russell 3000FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed power generation. The company offers SureSource product line based on carbonate fuel cell technology in various configurations, including on-site power, utility grid support, distributed hydrogen, and micro-grid, as well as multi-megawatt applications; and SureSource Recovery power plants for natural gas pipeline applications. It also provides SureSource Capture system that separates carbon dioxide from the flue gases of natural gas, biomass, or coal-fired power plants, as well as industrial facilities; and SOFC/SOEC and Energy Storage, a solution for energy storage using solid oxide technology. The company's SureSource power plants generate electricity and usable heat. It serves various markets, such as utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, and Germany. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut. On 06/26/20, FCEL announced it was joining the Russell 3000 On 06/12/20, FCEL announced record earnings with an inline on EPS and a beat of $18.90 million on revenue. Revenue increased 105.08% over sales of $9.22 million the same period last year. Currently, Daily Chart looks good. PMO is rising, Bullish MACD is rising, Bullish OBV is rising, Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:FCELLong
by HotCharts
2
Bullish Charts - Uranium PlayCameco Corporation produces and sells uranium. The company operates in two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. Its operating uranium property is the Cigar Lake property located in Saskatchewan, Canada. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles and reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada. Cameco Corporation is one of the world's largest uranium producers, a significant supplier of conversion services and one of two CANDU fuel manufacturers in Canada. Their competitive position is based on their controlling ownership of the world's largest high-grade reserves and low-cost operations. Over the last four quarters, the stock’s earnings surpassed the Zacks Consensus Estimate thrice . finance.yahoo.com On May 20, 2020, U.S. Department of Energy rushes to build advanced new nuclear reactors www.sciencemag.org On 06/26/20, Cameco issued a press release relating to its win in the appeals court for tax issues. With the court win, Cameco should be receiving over $300 Million back from the Canadian Government plus another $482 million back in letters of credit that Cameco was required to pay as installments. transferpricingnews.com The tax court win was a HUGE win for Cameco and will free up hundreds of millions of dollars. Daily Chart Looks Bullish Volume, Bullish PMO, Bullish MACD, Bullish Stochastic, Bullish OBV, Bullish On 06/30/2020, Raymond James issued an Outperform rating on Cameco. On 06/25/2020, BMO Capital Markets raised the price target to C$17.00. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:CCJLong
by HotCharts
Space Travel + CESIUM = Possible GamechangerPretium Resources Inc. acquires, explores for, and develops precious metal resource properties in the Americas. The company primarily explores for gold, silver, and copper deposits. Its principal project is the Brucejack project that consists of 4 mining leases and 6 mineral claims covering an area of 3,305.85 hectares located in northwestern British Columbia. It also owns 100% interest in the Snowfield project consisting of 1 mineral claim covering an area of 1,217 hectares located in northern British Columbia. The company was founded in 2010 and is headquartered in Vancouver, Canada. On 06/04/2020, PR Newswire posted a story about Space Travel and an Unknown Metal called Cesium www.prnewswire.com www.prnewswire.com www.kitco.com In the article, it went on to say that Cesium can be used in ion propulsion systems, with 1 kilogram of Cesium used in outer space able to propel a vehicle 140 times as far as any other known liquid or solid, but it could be the game-changer for solar system navigation. Cesium is a critical element of Global Positioning Systems (GPS). Atomic clocks track vibrations inside Cesium to measure time accurately. The same goes for GPS satellites orbiting Earth. It's only because of Cesium that they are able to precisely triangulate. Now, the prospects of deep space make Cesium even more critical. Future missions in deep space could navigate the solar system with a form of GPS-and the defining moment will be the successful testing of the Deep Space Atomic Clock. It will also be a huge part of the brewing "Cold War" with China. The "Cold War" with China is being played out on multiple fronts: Control of critical metals, dominance over 5G, national security and deep space. All these fronts involve Cesium (Cs). China has been in control of almost 100% of the world's Cesium but now, Washington is stepping up its game by adding Cesium to the United States list of critical minerals in 2018. The article also said Pretium Resources (PVG) has an impressive portfolio with a huge opportunity for upside. Construction and engineering activities at its top Cesium location continue to advance, and commercial production is targeted for this year. On 05/01/20, PVG announced earnings that rocked Wall Street Estimates coming in at $0.140 Beats $0.06 Estimate, Sales $126.560 Million Beat $83.480 Million Estimate. Price targets are continuing to rise. On 05/19/20, B. Riley lifted Pretium Resources Price Target to $28 from $27, Keeps Buy Rating. - What does B. Riley know that we don't.??? The Daily Chart looks Bullish Volume is Bullish and rising PMO is trending up, Bullish MACD is trending up, Bullish RSI just crossed up over the center line, Bullish Stochastic is trending up, Bullish Sector is Bullish PVG is getting ready to break out above the cloud. 6-Jul-20 8.53 ▲ Mon PVG New York 6-Jul-20 8.53 Bullish Kijun Sen Cross 2-Jul-20 8.17 Bullish Tenkan/Kijun Cross 19-Jun-20 8.36 Bullish Chikou Span Cross Strong " " Bullish Kumo Breakout Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
PLong
by HotCharts
1
Bullish Charts - Golden Cross Soon, Possible BuyoutMicron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU); Mobile Business Unit (MBU); Storage Business Unit (SBU); and Embedded Business Unit (EBU). The Compute and Networking Business Unit segment includes memory products sold into cloud server, enterprise, client, graphics, and networking markets. The Mobile Business Unit segment offers memory products sold into smartphone, and other mobile-device markets. The Storage Business Unit segment comprises of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer solid-state drive (SSD) markets, other discrete storage products sold in component and wafer forms to the removable storage markets, and sales of 3D XPoint memory. The Embedded Business Unit segment consists of memory and storage products sold into automotive, industrial, and consumer markets. The company was founded by Ward D. Parkinson, Joseph L. Parkinson, Dennis Wilson, and Doug Pitman in October 1978 and is headquartered in Boise, ID. At current levels, I feel Micron is undervalued and unappreciated. There are not many devices in the technology industry that do not need memory and storage. Micron can supply the memory and storage from electric vehicles to computers and spaceships to airplanes. Almost everything today needs memory including appliances and smart homes. Micron just posted earnings and they blew past Wall Street estimates and then the company raised guidance and forecast higher earnings and revenue moving forward. Currently, on the Daily Chart, the following indicators are Bullish... Volume, Bullish MACD, Bullish RSI, Bullish Accumulation, Bullish Sector, Bullish PMO is turning up, Bullish On June 30, the 50-Day MA crossed up above the 100-Day MA, Bullish As of today, the 50-Day MA is less than a point away from crossing up above the 200-Day MA, Bullish Here are the indicators... 6-Jul-20 50.92 ▲ Mon MU New York 6-Jul-20 50.92 Bullish Kijun Sen Cross Strong 27-May-20 49.45 Bullish Kumo Breakout 26-May-20 45.80 Bullish Chikou Span Cross 4-May-20 44.46 Bullish Senkou Span Cross In my opinion, I think Micron is the best play in town and I also think it's a buyout target. If I were the CEO of Microsoft or another large tech giant like Apple, I wouldn't even think twice about trying to buyout Micron because down the road, everything will need memory and storage to operate. If Micron is bought, I think the buyout would be upwards of $120 per share. This was from 2016 and in my opinion, Micron looks better now than ever before... If it looked good in 2016, it looks amazing now! Chipmaker Micron Gains with Speculation It's a Takeover Target www.industryweek.com Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:MULong
by HotCharts
4
Bullish Charts - Golden Cross, July 6 Conf CallObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing OBE022, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland. On 06/29/20, ObsEva announced it will hold a conference call to discuss results from Phase 3 PRIMROSE 1 and PRIMROSE 2 clinical trials evaluating their drug Linzagolix in women with Uterine Fibroids. I personally think the conference call will be Bullish because on 07/01/20, ObsEva and Yuyuan BioScience Technology announced submission of the PRE-IND Dossier for Nolasiban with Chinese NMPA. This company has a few things going on that could be a catalyst for the stock moving into July 6, next week. Daily Chart is Bullish 50-Day MA just crossed up above the 200-Day MA - I believe this cross just happened today on above average volume. MACD is turning up, Bullish RSI is Bullish Stochastic is Bullish The Cloud indicators are all Bullish as seen below. 8-May-20 3.36 Bullish Kumo Breakout 5-May-20 2.95 Bullish Senkou Span Cross 4-May-20 2.41 Bullish Kijun Sen Cross 29-Apr-20 2.55 Bullish Tenkan/Kijun Cross 20-Apr-20 2.10 Bullish Chikou Span Cross Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
OLong
by HotCharts
1